In vitro studies performed after the silencing of syntenin-1 showed attenuation in the growth rate of MDA-MB-231 cells, whereas, in nude mice, the tumor volume was significantly lower (90%, p ≤ 0.05) in shRNA-treated mice. Here, SDCBP is linked to neoplasm.